Co-occurrence, possible origin, and health-risk assessment of arsenic and fluoride in drinking water sources in Mexico: Geographical data visualization

Arsenic and fluoride in drinking water present a significant challenge to public health worldwide. In this study, we analyze the results of one of the largest surveys of drinking water quality in Mexico: 14,058 samples from 3951 sites, collected between January and December 2017. We use these data to identify the distribution and possible origin of arsenic and fluoride in drinking water throughout the country, and to estimate the associated health burden. The highest concentrations appear in alluvial aquifers in arid northern Mexico, where high-silica volcanic rock likely releases both arsenic and fluoride to the groundwater. We find fluoride contamination to be significantly correlated with aridity (Pearson correlation = −0.45, p = 0.0105), and also find a significant difference in fluoride concentrations between arid and humid states (Welch's t-test, p = 0.004). We estimate population exposure by assigning to each town in Mexico the average concentration of any sampling sites within 5 km. Our results show that 56% of the Mexican population lives within 5 km of a sampling site, 3.05 million people are exposed to fluoride above the reference dosage of 0.06 mg/(kg ∗ day), 8.81 million people are exposed to arsenic above the limit of 10 μg/L, and an additional 13,070 lifetime cases of cancer are expected from this arsenic exposure alone. This burden of disease is concentrated in the arid states of north-central Mexico

Centrality evolution of the charged-particle pseudorapidity density over a broad pseudorapidity range in Pb-Pb collisions at root s(NN)=2.76TeV

Peer reviewe

Photocatalysis for arsenic removal from water: considerations for solar photocatalytic reactors

The following work provides a perspective on the potential application of solar heterogeneous photocatalysis, which is a nonselective advanced oxidation process considered as a sustainable technology, to assist in arsenic removal from water, which is a global threat to human health. Heterogeneous photocatalysis can oxidize trivalent arsenic to pentavalent arsenic, decreasing its toxicity and easing its removal with other technologies, such as chemical precipitation and adsorption. Several lab-scale arsenic photocatalytic oxidation and diverse solar heterogeneous photocatalytic operations carried out in different reactor designs are analyzed. It was found out that this technology has not been translated to operational pilot plant scale prototypes. General research on reactors is scarce, comprising a small percentage of the photocatalysis related scientific literature. It was possible to elucidate some operational parameters that a reactor must comply to operate efficiently. Reports on small-scale application shed light that in areas where other water purification technologies are economically and/or technically not suitable, and the solar energy is available, shed light on the fact that solar heterogeneous photocatalysis is highly promissory within a water purification process for removal of arsenic from water

Emerging mitigation needs and sustainable options for solving the arsenic problems of rural and isolated urban areas in Latin America - a critical analysis

In this work, current information about the contamination of ground- and surface-water resources by arsenic from geogenic sources in Latin America is presented together with possible emerging mitigation solutions. The problem is of the same order of magnitude as other world regions, such as SE Asia, but it is often not described in English. Despite the studies undertaken by numerous local researchers, and the identification of proven treatment methods for the specific water conditions encountered, no technologies have been commercialized due to a current lack of funding and technical assistance.Emerging, low-cost technologies to mitigate the problem of arsenic in drinking water resources that are suitable for rural and urban areas lacking centralized water supplies have been evaluated. The technologies generally use simple and low-cost equipment that can easily be handled and maintained by the local population. Experiences comprise (i) coagulation/filtration with iron and aluminum salts, scaled-down for small community- and household-scale-applications, (ii) adsorption techniques using low-cost arsenic sorbents, such as geological materials (clays, laterites, soils, limestones), natural organic-based sorbents (natural biomass), and synthetic materials. TiO2-heterogeneous photocatalysis and zerovalent iron, especially using nanoscale particles, appear to be promising emergent technologies. Another promising innovative method for rural communities is the use of constructed wetlands using native perennial plants for arsenic rhizofiltration. Small-scale simple reverse osmosis equipment (which can be powered by wind or solar energy) that is suitable for small communities can also be utilized.The individual benefits of the different methods have been evaluated in terms of (i) size of the treatment device, (ii) arsenic concentration and distribution of species, chemical composition and grade of mineralization in the raw water, (iii) guidelines for the remaining As concentration, (iv) economical constrains, (v) complexity of installation and maintenance, and infrastructure constraints (e.g. electricity needs)

Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases

Objective I mmune-mediated inflammatory diseases (IMIDs) are heterogeneous and complex conditions with overlapping clinical symptoms and elevated familial aggregation, which suggests the existence of a shared genetic component. In order to identify this genetic background in a systematic fashion, we performed the first cross-disease genome-wide meta-analysis in systemic seropositive rheumatic diseases, namely, systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and idiopathic inflammatory myopathies. Methods We meta-analysed similar to 6.5 million single nucleotide polymorphisms in 11 678 cases and 19 704 non-affected controls of European descent populations. The functional roles of the associated variants were interrogated using publicly available databases. Results Our analysis revealed five shared genome-wide significant independent loci that had not been previously associated with these diseases: NAB1, KPNA4-ARL14, DGQK, LIMK1 and PRR12. All of these loci are related with immune processes such as interferon and epidermal growth factor signalling, response to methotrexate, cytoskeleton dynamics and coagulation cascade. Remarkably, several of the associated loci are known key players in autoimmunity, which supports the validity of our results. All the associated variants showed significant functional enrichment in DNase hypersensitivity sites, chromatin states and histone marks in relevant immune cells, including shared expression quantitative trait loci. Additionally, our results were significantly enriched in drugs that are being tested for the treatment of the diseases under study. Conclusions We have identified shared new risk loci with functional value across diseases and pinpoint new potential candidate loci that could be further investigated. Our results highlight the potential of drug repositioning among related systemic seropositive rheumatic IMIDs

Rivaroxaban with or without aspirin in stable cardiovascular disease

BACKGROUND: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. METHODS: In this double-blind trial, we randomly assigned 27,395 participants with stable atherosclerotic vascular disease to receive rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg once daily), rivaroxaban (5 mg twice daily), or aspirin (100 mg once daily). The primary outcome was a composite of cardiovascular death, stroke, or myocardial infarction. The study was stopped for superiority of the rivaroxaban-plus-aspirin group after a mean follow-up of 23 months. RESULTS: The primary outcome occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (379 patients [4.1%] vs. 496 patients [5.4%]; hazard ratio, 0.76; 95% confidence interval [CI], 0.66 to 0.86; P<0.001; z=−4.126), but major bleeding events occurred in more patients in the rivaroxaban-plus-aspirin group (288 patients [3.1%] vs. 170 patients [1.9%]; hazard ratio, 1.70; 95% CI, 1.40 to 2.05; P<0.001). There was no significant difference in intracranial or fatal bleeding between these two groups. There were 313 deaths (3.4%) in the rivaroxaban-plus-aspirin group as compared with 378 (4.1%) in the aspirin-alone group (hazard ratio, 0.82; 95% CI, 0.71 to 0.96; P=0.01; threshold P value for significance, 0.0025). The primary outcome did not occur in significantly fewer patients in the rivaroxaban-alone group than in the aspirin-alone group, but major bleeding events occurred in more patients in the rivaroxaban-alone group. CONCLUSIONS: Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better cardiovascular outcomes and more major bleeding events than those assigned to aspirin alone. Rivaroxaban (5 mg twice daily) alone did not result in better cardiovascular outcomes than aspirin alone and resulted in more major bleeding events

In COVID-19 health messaging, loss framing increases anxiety with little-to-no concomitant benefits: Experimental evidence from 84 countries

The COVID-19 pandemic (and its aftermath) highlights a critical need to communicate health information effectively to the global public. Given that subtle differences in information framing can have meaningful effects on behavior, behavioral science research highlights a pressing question: Is it more effective to frame COVID-19 health messages in terms of potential losses (e.g., “If you do not practice these steps, you can endanger yourself and others”) or potential gains (e.g., “If you practice these steps, you can protect yourself and others”)? Collecting data in 48 languages from 15,929 participants in 84 countries, we experimentally tested the effects of message framing on COVID-19-related judgments, intentions, and feelings. Loss- (vs. gain-) framed messages increased self-reported anxiety among participants cross-nationally with little-to-no impact on policy attitudes, behavioral intentions, or information seeking relevant to pandemic risks. These results were consistent across 84 countries, three variations of the message framing wording, and 560 data processing and analytic choices. Thus, results provide an empirical answer to a global communication question and highlight the emotional toll of loss-framed messages. Critically, this work demonstrates the importance of considering unintended affective consequences when evaluating nudge-style interventions

Direct observation of the dead-cone effect in quantum chromodynamics

The direct measurement of the QCD dead cone in charm quark fragmentation is reported, using iterative declustering of jets tagged with a fully reconstructed charmed hadron